START New Jersey

START New Jersey is a dedicated Phase 1 clinical research site specializing in oncology. As part of the global START (South Texas Accelerated Research Therapeutics) network, the facility provides cancer patients with access to early-stage clinical trials for novel investigational therapies. The center focuses on bridging the gap between laboratory research and clinical application, offering a range of services including pharmacokinetic analysis and regulatory support. By partnering with pharmaceutical and biotechnology companies, START New Jersey facilitates the development of next-generation cancer treatments in a community-based setting.